drugset / Trial / NCT03890341

Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440

NCT03890341

NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to evaluate the effect of JNJ-64530440 single- and multiple-dose administration on the single-dose pharmacokinetics of drospirenone and ethinylestradiol (oral contraceptive) in healthy female participants.

Timeline

Start
2021-06-01
Primary completion
2021-08-01
Completion
2021-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ-64530440 Unknown 2000 mg Oral
Subject Midazolam Small molecule 2 mg Oral
Subject drospirenone Unknown 3 mg Oral
Subject ethinyl estradiol Small molecule 0.02 mg Oral

Indications

No indication recorded.